Excellent Relapse-Free and Overall Survival in Pre-HCT Next-Generation Sequencing (NGS-MRD) Negative B-ALL Patients with or without TBI-Based Conditioning: Outcome of the Observational Arm of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) ONC1701 Endrad StudyHisham Abdel‐Azim, Michael A. Pulsipher, Neena Kapoor et al.|Transplantation and Cellular Therapy|2023Cited by 5
High event-free (EFS) and overall survival (OS) after non-total body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL): Results from the EndRAD trial (PTCTC ONC1701)Hisham Abdel-Azim, Michael A. Pulsipher, Troy C. Quigg et al.|Blood|2025Cited by 2